Pablo Bagnati

The landscape of dementia research, diagnosis, treatment, and care in Latin America

Claudia K. Suemoto, Nilton Custodio, Diego Alonso Gómez Aguilar, José A. Avila‐Funes et autres

Latin America is undergoing rapid population aging alongside a rising burden of dementia. While the region holds substantial potential for dementia risk reduction, challenges remain, such as delayed diagnoses, limited access to specialized care and biomarker testing, persistent stigma, and deep-rooted structural …

br, pe, gb, fr, mx, co, ar, us, nl, cl, ie, tr, es, cr, cu, au, ec (code pays fourni par la source)

Consenso Argentino para el diagnóstico de Diagnóstico de las demencias. Primera parte: introducción, metodología de trabajo, escenario actual y algoritmos diagnósticos

Pablo Bagnati, Ricardo F. Allegri, Ignacio Demey, Gastón Bartoli et autres

The Argentine Consensus on the Diagnosis of Dementia is an initiative of the Argentine Association of Biological Psychiatry (AAPB). The primary aim of this document was to develop an efficient tool for the early diagnosis of dementia, targeting both primary care physicians …

ar, br, us, cu, co (code pays fourni par la source)

Impact of genetic counseling and testing in individuals at high risk for Alzheimer ´s Disease from Latin America

Pablo Bagnati, David Fernando Aguillon, Marisol Londoño Castaño, María Laura Fernández et autres

BACKGROUND: This study evaluates a tailored genetic counseling and testing (GTC) protocol for families at risk of Autosomal Dominant Alzheimer ´s Disease (ADAD) in Latin America, focusing on the essential cultural and regional adaptations. Several factors may influence the decision of whether …

ar, co, es, mx, us (code pays fourni par la source)

New Alzheimer's disease diagnostic criteria 2024: Biological vs Clinical-biological criteria

Ricardo Allegri, Pablo Bagnati

Regarding the development of Alzheimer’s disease biomarkers, the diagnostic criteria for the disease have been modified. Up to now, they have only been used in research, but with the advent of new biological treatments with anti-amyloid antibodies, they are beginning to be …

Impact of genetic counseling and testing in individuals at high risk of familial Alzheimer's disease from Latin America: a non‐randomized controlled trial

Pablo Bagnati, Marisol Londoño Castaño, M. Laura Fernández, Beatriz Mora Henao et autres

INTRODUCTION: This study involved evaluating a tailored genetic counseling and testing (GCT) protocol for families at risk of autosomal dominant Alzheimer's disease (ADAD) in Latin America (LatAm), focusing on essential cultural and regional adaptations. METHODS: We conducted a non-randomized controlled trial among …

ar, co, mx, us (code pays fourni par la source)

Behavioral variant frontotemporal dementia (bvFTD): PET biomarker characterization of metabolism (18F‐FDG), amyloid (11C‐PIB) and tau (18F‐AV1451) and its clinical correlate ‐ analysis of a cohort from Argentina

Nahuel Magrath Guimet, Germán Falasco, Yanina Bérgamo, Julio Jose Herrera et autres

INTRODUCTION: Imaging biomarkers are fundamental in diagnosing neurodegenerative diseases, but their use in FTD remains limited. This study examines PET biomarkers in Argentine bvFTD patients. METHODS: We studied a cohort of bvFTD patients (n = 20) and controls (n = 21) with …

us, ar, co (code pays fourni par la source)

Genetic Screening of Frontotemporal Dementia Patients from a Memory Clinic in Argentina

A. Ojeda, Nahuel Magrath Guimet, Pablo Bagnati, Ricardo Allegri et autres

BACKGROUND: Frontotemporal dementia (FTD) remains one of the most common forms of early-onset dementia (45 to 65 years). FTD consists clinically and pathologically of a heterogeneous group of disorders characterized by progressive frontal and temporal lobe atrophy. Thirty to fifty percent of …

ar (code pays fourni par la source)

Genetic counseling and testing in individuals at high risk for familial Alzheimer’s Disease from Latin America

Jorge J. Llibre‐Guerra, Pablo Bagnati, Marisol Londoño Castaño, María Lameiras Fernández et autres

Abstract Background Genetic testing for individuals with dominantly inherited Alzheimer’s disease (DIAD) is now of greater relevance due to the existence of therapeutic trials available to this population. However, the impact and main drivers influencing the decision to seek genetic testing are …

us, ar, co (code pays fourni par la source)

Functional cognitive disorder: Beyond pseudodementia

Daniel S. Marín‐Medina, Paula A. Arenas-Vargas, María del Pilar Velásquez-Duque, Pablo Bagnati

Many patients with cognitive symptoms, such as subjective memory complaints, may in fact have functional cognitive disorder. This review explores various aspects of functional cognitive disorder. We describe the clinical characteristics that support diagnosis. Diagnosis is not made by exclusion; rather, it …

co, es, ar (code pays fourni par la source)

Cognitive Dysfunction in Addictions

Marcela Waisman Campos, Pablo Bagnati

ar (code pays fourni par la source)

PET biomarkers in behavioral variant Frontotemporal dementia: analysis of an Argentine cohort.

Nahuel Magrath Guimet, Germán Falasco, Pablo Bagnati, Silvia Vázquez et autres

Abstract Background Behavioral variant frontotemporal dementia (bvFTD) is a neurodegenerative disorder characterized by early and progressive changes in behavior, emotional processing and executive control. This entity represents a diagnostic challenge in which positron emission tomography (PET) may play a key role in …

ar, us (code pays fourni par la source)

Evaluación Neurocognitiva en las Adicciones

Marcela Waisman Campos, Cecilia Verónica Cervino, Pablo Bagnati, Rodrigo Eduardo Navarro et autres

Introducción: Este artículo pretende ofrecer una breve revisión de las pruebas recientes que consideran los factores cognitivos relacionados con la adicción.Las observaciones clínicas, la sabiduría convencional y los mecanismos teóricos bien razonados sugieren que el uso agudo y crónico de sustancias psicoactivas …

ar, py, br, it (code pays fourni par la source)